Combo HTN product gets final approval

July 2007
Drug Topics;7/9/2007, Vol. 151 Issue 13, p6
Trade Publication
This article reports that Exforge from Novartis has received final approval for its combination product used to treat hypertension. The company said that it is the first medication to combine an angiotensin receptor blocker and a calcium-channel blocker into a tablet taken once daily. Two clinical trials studied Exforge in which nine out of ten patients reached their treatment goal of diastolic blood pressure less than 90 mmHg or more than a 10 mmHg reduction in diastolic blood pressure from baseline level.


Related Articles

  • Which thiazide to choose as add-on therapy for hypertension? Barrios, Vivencio; Escobar, Carlos // Integrated Blood Pressure Control;2014, Vol. 7, p35 

    Combined therapy is required in the majority of patients with hypertension to achieve blood pressure (BP) targets. Although different antihypertensive drugs can be combined, not all combinations are equally effective and safe. In this context, the combination of a renin angiotensin system...

  • From the Editors' Desk: Why NCATS Should Read this Issue of JGIM. Kravitz, Richard // JGIM: Journal of General Internal Medicine;Jun2012, Vol. 27 Issue 6, p613 

    An introduction is presented in which the editor discusses various reports within the issue on topics including blood pressure measurement for hypertension, effectiveness of angiotensin converting enzyme (ACE) -inhibitors and angiotensin receptor blockers (ARBs), and nurse management intervention.

  • Management guidelines in essential hypertension: report of the second working party of the British Hypertension Society. Server, Peter; Beevers, Gareth; Bulpitt, Christopher; Lever, Anthony; Ramsay, Larry; Reid, John; Swales, John // BMJ: British Medical Journal (International Edition);4/10/93, Vol. 306 Issue 6883, p983 

    Focuses on the management of patients with hypertension in Great Britain. Issuance of guidelines by the British Hypertension Society on blood pressure measurement; Importance of non-pharmaceutical measures; Evaluation of the 24 hour ambulatory blood pressure monitoring.

  • Coronary flow reserve and the J curve relation between diastolic blood pressure and myocardial infarction. Cruickshank, John M. // BMJ: British Medical Journal (International Edition);11/12/88, Vol. 297 Issue 6658, p1227 

    Reports the long term studies of patients with hypertension. Relation between diastolic blood pressure during treatment and myocardial infarction; Evaluation of coronary flow of patients with hypertension; Treatment of coronary heart disease.

  • Home Blood Pressure Monitoring. Kriesand, Terri; Cohen, Irvin M. // American Family Physician;8/1/1996, Vol. 54 Issue 2, p537 

    Focuses on the need to monitor blood pressure in patients with hypertension in their home and work environment. Advantages and disadvantages of home blood pressure monitoring; Description of various devices available for home blood pressure monitoring; Overview of problems related to the...

  • Monitoring Your Blood Pressure at Home.  // American Family Physician;8/1/1996, Vol. 54 Issue 2, p545 

    Presents answers to various queries related to blood pressure monitoring at home in patients with hypertension. Need to measure blood pressure at home; Information on aneroid monitor, an equipment to be used to monitor blood pressure at home; Advantages and disadvantages of digital monitor, an...

  • Continuous blood-pressure recording.  // British Medical Journal;11/3/1979, Vol. 2 Issue 6198, p1126 

    Examines the benefits of continuous blood-pressure recording among ambulatory hypertensive patients. Variations in individual blood-pressure response to stress and activity; Inaccuracy of casual blood-pressure measurement of patients with borderline hypertension; Evidence of complications...

  • Effect of antihypertensive treatment on office and self-measured blood pressure: The Autodil Study. Leeman, M J; Lins, R L; Sternon, J E; Huberlant, B C; Fassotte, C E // Journal of Human Hypertension;Aug2000, Vol. 14 Issue 8, p525 

    Objective: To examine prospectively the effects of antihypertensive therapy on office blood pressure (BP) and home BP, in a large-scale hypertensive population followed by their general practitioners. Patients: A total of 760 hypertensive patients either never treated or after a 2-week washout...

  • Aggressive treatment strategies expand pharmacists' role in managing hypertension. Roller, Kim // Drug Store News;7/19/99, Vol. 21 Issue 11, pCP1 

    Urges the healthcare professionals to adopt an aggressive management strategies in blood pressure control to reduce cardiovascular risk. Comments from Charles Ponte of the University of West Virginia; Roles of pharmacists in hypertension programs; Cost of hypertensive drugs.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics